JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5301
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.82B
| $70K | ﹤0.01% |
2,525
| – | – |
2019 Q3
11 quarters
|
|
|
PR
5302
PUT
Permian Resources
PR
$18.4B
| $70K | ﹤0.01% |
11,700
+200
| +2% | +$1.6K |
2021 Q1
5 quarters
|
|
|
SOND
5303
DELISTED
Sonder
SOND
| $70K | ﹤0.01% |
3,382
+2,809
| +490% | +$160K |
2021 Q4
2 quarters
|
|
5304
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.02B
| $70K | ﹤0.01% |
826
+50
| +6% | +$4.57K |
2017 Q4
18 quarters
|
|
5305
BGSF Inc
BGSF
$53.2M
| $69K | ﹤0.01% |
5,556
-1,233
| -18% | -$15.4K |
2016 Q4
22 quarters
|
|
5306
Fennec Pharmaceuticals
FENC
$362M
| $69K | ﹤0.01% |
7,735
-8,631
| -53% | -$50.1K |
2021 Q4
2 quarters
|
|
5307
Alpha Pro Tech
APT
$51.7M
| $68K | ﹤0.01% |
15,303
+15,263
| +38,158% | +$65K |
2020 Q2
8 quarters
|
|
5308
CALL
Norfolk Southern
NSC
$69.7B
| $68K | ﹤0.01% |
300
-14,400
| -98% | -$3.54M |
2021 Q3
3 quarters
|
|
5309
Navigator Holdings
NVGS
$1.46B
| $68K | ﹤0.01% |
6,035
-18,101
| -75% | -$234K |
2018 Q1
17 quarters
|
|
5310
CALL
Planet Fitness
PLNT
$3.16B
| $68K | ﹤0.01% |
+1,000
| New | +$73.9K |
2022 Q2
0 quarters
|
|
5311
The Beachbody Company
BODI
$34.6M
| $68K | ﹤0.01% |
1,132
+1,120
| +9,333% | +$90.8K |
2021 Q3
3 quarters
|
|
|
GRNA
5312
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $68K | ﹤0.01% |
30,476
+28,670
| +1,587% | +$199K |
2022 Q1
1 quarter
|
|
5313
Global X Cloud Computing ETF
CLOU
$380M
| $67K | ﹤0.01% |
4,073
-703
| -15% | -$13.1K |
2020 Q4
6 quarters
|
|
|
LSEAW
5314
DELISTED
Landsea Homes Corporation Warrant
LSEAW
| – | – |
0
| – | – |
2021 Q2
4 quarters
|
|
5315
Shattuck Labs
STTK
$686M
| $67K | ﹤0.01% |
16,671
-8,880
| -35% | -$32.2K |
2020 Q4
6 quarters
|
|
5316
CALL
TJX Companies
TJX
$147B
| $67K | ﹤0.01% |
1,200
-435,100
| -100% | -$26.3M |
2021 Q4
2 quarters
|
|
|
5317
PUT
TJX Companies
TJX
$147B
| $67K | ﹤0.01% |
+1,200
| New | +$72.6K |
2022 Q2
0 quarters
|
|
5318
USCB Financial Holdings
USCB
$408M
| $67K | ﹤0.01% |
5,763
+958
| +20% | +$12.7K |
2021 Q4
2 quarters
|
|
|
SNCE
5319
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $67K | ﹤0.01% |
1,664
+935
| +128% | +$68.3K |
2021 Q4
2 quarters
|
|
5320
CALL
Strategy Inc
MSTR
$64B
| $66K | ﹤0.01% |
+4,000
| New | +$116K |
2022 Q2
0 quarters
|
|
5321
VirTra
VTSI
$31.2M
| $66K | ﹤0.01% |
13,461
-3,157
| -19% | -$16.1K |
2021 Q3
3 quarters
|
|
|
ICPT
5322
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $66K | ﹤0.01% |
+4,800
| New | +$76.9K |
2022 Q2
0 quarters
|
|
5323
Fresenius Medical Care
FMS
$11.8B
| $65K | ﹤0.01% |
2,593
-120
| -4% | -$3.59K |
2013 Q2
36 quarters
|
|
5324
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$405M
| $65K | ﹤0.01% |
4,262
| – | – |
2013 Q2
36 quarters
|
|
5325
Outlook Therapeutics
OTLK
$140M
| $65K | ﹤0.01% |
3,169
+496
| +19% | +$14.3K |
2021 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.